Nasdaq gains more than 1.4% in biggest rally of 2017

MYL

5 Trump-Proof Pharma Dividend Stocks to Buy

Pharma is under the proverbial gun as Trump takes office, but these pharma dividend payers are stocks to buy for the long term More 

7 Healthcare Stocks That Will Cripple Your Portfolio

Healthcare is undergoing significant transition, so avoid the weakest ones that are prone to downside risk under the incoming administration. More 

CVS Health Corp (CVS) to Sell Cheaper Generic Version of EpiPen

CVS Health Corp (CVS) has announced that it is now selling a generic version of EpiPen that is much cheaper than the name brand. More 

Cigna Corporation (CI) Stops Covering EpiPen by Mylan NV (MYL)

Cigna Corporation (CI) will no longer be covering the expensive EpiPen made by Mylan NV (MYL) now that a generic version is available. More 

TEVA, MYL Among Six Drug Makers Accused of Price Fixing in U.S.

A pharma price fixing scandal has hit Teva Pharmaceutical Industries Ltd (ADR) and Mylan hard. Here's what you should know about the travesty. More 

Mylan NV Layoffs: EpiPen Maker MYL Plans Job Cuts, Restructure

EpiPen maker Mylan NV has announced that that the company is launching a restructuring plan that will lead to up to 3,500 losing their jobs. More 

3 Beaten-Down Generic Drugmakers to Buy

Generic drugmakers Mylan (MYL), Teva (TEVA) and Novartis (NOV) took a hit from DOJ subpoenas on speculation of price-fixing in the industry. More